ArticleFrontiers in oncology2022

Efficacy of crizotinib retreatment after crizotinib-related interstitial lung disease in a patient with ROS1-rearranged advanced lung adenocarcinoma: A case report and potential crizotinib retreatment strategy.

Woo Kyung Ryu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.